CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...